Find your next paid study

Red Rock Regeneration Inc.NCT06971835

~$10 – $1,050

Actual pay is set by the research site.

Hematopoietic and Lymphoid System NeoplasmMalignant Solid Neoplasm

Geriatric Assessment (GA)-Driven Interventions With Supportive Care (The GAIN-S Trial): Telemedicine to Increase Goal Concordant Care for Older Adults With Cancer in the Community

This clinical trial evaluates whether geriatric assessment-driven interventions with supportive care (GAIN-S) using telemedicine can be used to identify areas …

City of Hope Medical CenterNCT06022965

Actual pay is set by the research site.

Phase 2

Impact of Microbiome Modulation With CBM588 in Combination With Pembrolizumab for Adjuvant Therapy of High-Risk, Resected Renal Cell Carcinoma (RCC)

This phase II trial compares the effect of adding a Live Biotherapeutic Product called CBM588 to pembrolizumab versus pembrolizumab alone in preventing return …

Clear Cell Renal Cell CarcinomaSarcomatoid Renal Cell CarcinomaStage II Renal Cell Cancer AJCC v8+2 more

City of Hope Medical CenterNCT07037004

~$75 – $2,000

Actual pay is set by the research site.

Borderline-resectable Pancreatic Cancer

DCE-MRI Guided Neoadjuvant Chemotherapy for Borderline Resectable Pancreatic Cancer

The goal of this study is to test whether chemotherapy guided by a new imaging method named DCE-MRI can more effectively reduce a pancreatic tumor, enabling cu…

Ohio State UniversityNCT06173310

Actual pay is set by the research site.

Traumatic Brain InjuryUpper Extremity

Transcutaneous Auricular Vagus Nerve Stimulation to Improve Upper Extremity Recovery After Traumatic Brain Injury: A Pilot Randomized Sham-Controlled Trial

Upper extremity weakness, impaired coordination, reduced dexterity, and limited arm and hand use may continue after TBI. Repetitive, task-specific rehabilitati…

Craig HospitalNCT07867015

Actual pay is set by the research site.

Phase 2

A Phase 2, Multicenter, Randomized, Double-blind, Placebo-controlled, Proof-of-concept Trial to Assess the Efficacy and Safety of SPY072 in Adults With Moderate to Severe Hidradenitis Suppurativa Receiving Standard of Care Treatment

This Phase 2 study will test whether the investigational medicine, SPY072, improves hidradenitis suppurativa (HS) in adults with moderate to severe disease rec…

Hidradenitis Suppurativa (HS)

Spyre Therapeutics, Inc.NCT07766005

~$75 – $2,800

Actual pay is set by the research site.

Remote vs. In-PersonRemote VisitsIn-person Visits

Remote vs. In-Person Study Evaluation (RISE) Above Opioid Overdose

The study will employ a randomized, parallel-group design with two-stage randomization. After an initial brief screen for basic eligibility, participants will …

State University of New York at BuffaloNCT07875569

Actual pay is set by the research site.

Phase 3

A Phase 3 Randomized, Placebo-controlled, Double-blind Program to Evaluate Efficacy and Safety of Upadacitinib in Adult and Adolescent Subjects With Severe Alopecia Areata

Alopecia areata (AA) is a disease that happens when the immune system attacks hair follicles and causes hair loss. AA usually affects the head and face, but ha…

Alopecia Areata

~$50 – $2,250

Actual pay is set by the research site.

AbbVieNCT06012240

Vision-MR Ablation Catheter 2.0 for Treatment of Type I Atrial Flutter

The VISABL-AFL clinical investigation is a prospective, single-arm, multi-center, interventional, Investigational Device Exemption (IDE) trial. The primary obj…

Atrial Flutter Typical

Imricor Medical SystemsNCT05904548

~$10 – $1,125

Actual pay is set by the research site.

Phase 1

A Phase 1/2a Study Evaluating the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of NTS071 in Subjects With Advanced Solid Tumors Harboring a TP53 Y220C Mutation

This study is to evaluate the safety, tolerability, PK, and preliminary efficacy of NTS071 in adults with TP53 Y220C-mutated solid tumors.

Advanced Solid Tumors

Nutshell Therapeutics (Shanghai) Co., LTD.NCT07060989

~$150 – $4,200

Actual pay is set by the research site.

Implementazione di Algoritmi di Intelligenza Artificiale Nello Studio Delle RMN Cerebrali di Pazienti Con Epilessia / Implementation of Artificial Intelligence Algorithms for the Analysis of Brain MRI Scans in Patients With Epilepsy

This study will test computer programs that help doctors read brain MRI scans. The programs use artificial intelligence (AI). The study includes people with ep…

Epilepsies

Istituto Giannina GasliniNCT07881185

~$10 – $1,125

Actual pay is set by the research site.

Phase 3

A Multicenter, 12-Month, Randomized, Double Blind, Placebo-Controlled Phase 3 Efficacy and Safety Study of Daily Oral LUM-201 in Naïve-to-Treatment, Prepubertal Children With Growth Hormone Deficiency (GHD)

The OraGrowtH Phase 3 Trial is a multi-national trial. The goals of the trial are to study LUM-201 as a treatment for Pediatric Growth Hormone Deficiency (PGHD…

Growth Hormone Deficiency (GHD)